Entero Healthcare [ENTERO] vs Royal Sense [ROYAL] Detailed Stock Comparison
Entero Healthcare
NSE
Loading...
Royal Sense
BSE
Loading...
TLDR: Quick Comparison Summary
Based on 18 vital metrics comparison: Entero Healthcare wins in 6 metrics, Royal Sense wins in 11 metrics, with 0 ties. Royal Sense appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Entero Healthcare | Royal Sense | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 51.29 | 19.29 | Royal Sense |
| Price-to-Book Ratio | 3.04 | 4.03 | Entero Healthcare |
| Debt-to-Equity Ratio | 21.76 | 11.74 | Royal Sense |
| PEG Ratio | 1.34 | N/A | N/A |
| EV/EBITDA | 27.52 | 11.51 | Royal Sense |
| Profit Margin (TTM) | 1.90% | 10.26% | Royal Sense |
| Operating Margin (TTM) | 2.94% | 14.32% | Royal Sense |
| EBITDA Margin (TTM) | 2.94% | 14.32% | Royal Sense |
| Return on Equity | 5.36% | 27.55% | Royal Sense |
| Return on Assets (TTM) | 3.51% | 19.67% | Royal Sense |
| Free Cash Flow (TTM) | $-881.78M | $-4.77M | Royal Sense |
| 1-Year Return | -2.62% | 57.26% | Royal Sense |
| Price-to-Sales Ratio (TTM) | 0.97 | 1.98 | Entero Healthcare |
| Enterprise Value | $53.62B | $1.02B | Entero Healthcare |
| EV/Revenue Ratio | 0.99 | 1.66 | Entero Healthcare |
| Gross Profit Margin (TTM) | 9.94% | 15.60% | Royal Sense |
| Revenue per Share (TTM) | $1,242 | $126 | Entero Healthcare |
| Earnings per Share (Diluted) | $23.52 | $11.82 | Entero Healthcare |
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends
Entero Healthcare vs Royal Sense Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Entero Healthcare | -0.12% | -4.11% | -3.93% | -17.10% | -1.97% | -15.97% |
| Royal Sense | 4.00% | 14.15% | 9.12% | 7.88% | -9.88% | -23.53% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Entero Healthcare | -2.62% | 4.95% | 4.95% | 4.95% | 4.95% | 4.95% |
| Royal Sense | 57.26% | 109.92% | 109.92% | 109.92% | 109.92% | 109.92% |
Performance & Financial Health Analysis: Entero Healthcare vs Royal Sense
| Metric | ENTERO | ROYAL |
|---|---|---|
| Market Information | ||
| Market Cap | ₹52.49B | ₹1.22B |
| Market Cap Category | Mid cap | Small cap |
| 10 Day Avg. Volume | 62,514 | 1,000 |
| 90 Day Avg. Volume | 76,993 | 2,250 |
| Last Close | ₹1,206.40 | ₹234.00 |
| 52 Week Range | ₹1,080.00 - ₹1,584.25 | ₹133.00 - ₹316.05 |
| % from 52W High | -23.85% | -25.96% |
| All-Time High | ₹1,584.25 (Nov 04, 2024) | ₹316.05 (Dec 30, 2024) |
| % from All-Time High | -23.85% | -25.96% |
| Growth Metrics | ||
| Quarterly Revenue Growth | 0.28% | 7.13% |
| Quarterly Earnings Growth | 0.38% | 7.93% |
| Financial Health | ||
| Profit Margin (TTM) | 0.02% | 0.10% |
| Operating Margin (TTM) | 0.03% | 0.14% |
| Return on Equity (TTM) | 0.05% | 0.28% |
| Debt to Equity (MRQ) | 21.76 | 11.74 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | ₹396.70 | ₹56.59 |
| Cash per Share (MRQ) | ₹73.09 | ₹22.95 |
| Operating Cash Flow (TTM) | ₹-1,784,970,000 | ₹11.39M |
| Levered Free Cash Flow (TTM) | ₹948.20M | ₹-32,393,500 |
| Dividends | ||
| Last 12-Month Dividend Yield | N/A | N/A |
| Last 12-Month Dividend | N/A | N/A |
Valuation & Enterprise Metrics Analysis: Entero Healthcare vs Royal Sense
| Metric | ENTERO | ROYAL |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 51.29 | 19.29 |
| Forward P/E | 23.58 | N/A |
| PEG Ratio | 1.34 | N/A |
| Price to Sales (TTM) | 0.97 | 1.98 |
| Price to Book (MRQ) | 3.04 | 4.03 |
| Market Capitalization | ||
| Market Capitalization | ₹52.49B | ₹1.22B |
| Enterprise Value | ₹53.62B | ₹1.02B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 0.99 | 1.66 |
| Enterprise to EBITDA | 27.52 | 11.51 |
| Risk & Other Metrics | ||
| Beta | N/A | N/A |
| Book Value per Share (MRQ) | ₹396.70 | ₹56.59 |
Financial Statements Comparison: Entero Healthcare vs Royal Sense
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | ENTERO | ROYAL |
|---|---|---|
| Revenue/Sales | ₹14.04B | ₹33.92M |
| Cost of Goods Sold | ₹12.64B | ₹28.63M |
| Gross Profit | ₹1.40B | ₹5.29M |
| Research & Development | N/A | N/A |
| Operating Income (EBIT) | ₹412.02M | ₹2.60M |
| EBITDA | ₹558.96M | ₹2.69M |
| Pre-Tax Income | ₹363.63M | ₹2.65M |
| Income Tax | ₹61.31M | ₹690,000 |
| Net Income (Profit) | ₹302.32M | ₹1.96M |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | ENTERO | ROYAL |
|---|---|---|
| Cash & Equivalents | ₹2.29B | ₹30.67M |
| Total Current Assets | ₹20.76B | ₹223.51M |
| Total Current Liabilities | ₹8.45B | ₹34.38M |
| Long-Term Debt | ₹670.18M | N/A |
| Total Shareholders Equity | ₹17.70B | ₹205.89M |
| Retained Earnings | N/A | N/A |
| Property, Plant & Equipment | ₹1.32B | N/A |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | ENTERO | ROYAL |
|---|---|---|
| Operating Cash Flow | N/A | ₹50.91M |
| Capital Expenditures | N/A | ₹233,000 |
| Free Cash Flow | N/A | ₹26.63M |
| Debt Repayment | N/A | N/A |
| Common Stock Repurchase | N/A | N/A |
Short Interest & Institutional Ownership Analysis
| Metric | ENTERO | ROYAL |
|---|---|---|
| Shares Short | N/A | N/A |
| Short Ratio | N/A | N/A |
| Short % of Float | N/A | N/A |
| Average Daily Volume (10 Day) | 62,514 | 1,000 |
| Average Daily Volume (90 Day) | 76,993 | 2,250 |
| Shares Outstanding | 43.51M | 4.97M |
| Float Shares | 13.64M | 1.48M |
| % Held by Insiders | 0.63% | 0.65% |
| % Held by Institutions | 0.22% | 0.00% |
Dividend Analysis & Yield Comparison: Entero Healthcare vs Royal Sense
| Metric | ENTERO | ROYAL |
|---|---|---|
| Last 12-Month Dividend | N/A | N/A |
| Last 12-Month Dividend Yield | N/A | N/A |
| 3-Year Avg Annual Dividend | N/A | N/A |
| 3-Year Avg Dividend Yield | N/A | N/A |
| 3-Year Total Dividends | N/A | N/A |
| Ex-Dividend Date | N/A | N/A |